Utility of physiologically based pharmacokinetic (PBPK) modeling in oncology drug development and its accuracy: a systematic review Teerachat SaehengKesara Na-BangchangJuntra Karbwang Review 05 July 2018 Pages: 1365 - 1376
Dexmedetomidine as a sedative and analgesic adjuvant in spine surgery: a systematic review and meta-analysis of randomized controlled trials Georgia G. TsaousiChryssa PourzitakiFederico Bilotta Review 14 July 2018 Pages: 1377 - 1389
A randomised controlled trial of the impact of structured written and verbal advice by community pharmacists on improving hypertension education and control in patients with high blood pressure Ejaz CheemaPaul SutcliffeDonald R. J. Singer Clinical Trial Open access 18 July 2018 Pages: 1391 - 1395
Clinical pharmacodynamics and long-term efficacy of Talcom vs. Plavix in patients undergoing coronary stent implantation: a randomized study with 5-year follow-up Jinshuang LiYuansheng FanChunjian Li Pharmacodynamics 20 August 2018 Pages: 1397 - 1403
Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin Sabina MugusiEliford NgaimisiEleni Aklillu Pharmacogenetics Open access 12 July 2018 Pages: 1405 - 1415
Effects of CYP2C19 and CYP3A5 genetic polymorphisms on the pharmacokinetics of cilostazol and its active metabolites Hye-In LeeJi-Young ByeonSeok-Yong Lee Pharmacogenetics 24 July 2018 Pages: 1417 - 1426
Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)—a pilot study Lanfranco PellesiManuela LicataSimona Guerzoni Pharmacokinetics and Disposition 06 July 2018 Pages: 1427 - 1436
Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes Can HuWen-jun YinXiao-cong Zuo Pharmacokinetics and Disposition 17 July 2018 Pages: 1437 - 1447
Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp. Pier Giorgio CojuttiManuela LuganoFederico Pea Pharmacokinetics and Disposition 21 July 2018 Pages: 1449 - 1459
Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients Hironari TanakaTakafumi NaitoJunichi Kawakami Pharmacokinetics and Disposition 26 July 2018 Pages: 1461 - 1469
Towards preventive pharmacovigilance through medicine misuse identification: an example with recombinant human growth hormone for aesthetic purposes Alfredo J. Rodrigues-NetoCamila Biazoni-AlbaricciAlbert Figueras Pharmacoepidemiology and Prescription 23 July 2018 Pages: 1471 - 1474
Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50 years Sylvie MesrineGaëlle GustoAgnès Fournier Pharmacoepidemiology and Prescription 04 July 2018 Pages: 1475 - 1484
Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder Koen P. GrootensAnna MeijerHenricus G. Ruhe Pharmacoepidemiology and Prescription 07 August 2018 Pages: 1485 - 1489
Correction to: Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder Koen P. GrootensAnna MeijerHenricus G. Ruhe Correction 14 September 2018 Pages: 1491 - 1491
Demographic, clinical and lifestyle factors associated with high-intensity statin therapy in Australia: the AusDiab study Karen HoKris M. JamsenJenni Ilomäki Pharmacoepidemiology and Prescription 19 July 2018 Pages: 1493 - 1501
Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding Borja RuizUrko AguirreCarmelo Aguirre Pharmacoepidemiology and Prescription 24 July 2018 Pages: 1503 - 1511
Discontinuation of non-anti-TNF drugs for rheumatoid arthritis in interventional versus observational studies: a systematic review and meta-analysis Fernanda S. ToninLaiza M. SteimbachAstrid Wiens Pharmacoepidemiology and Prescription 18 July 2018 Pages: 1513 - 1521
Barriers and facilitators of appropriate vancomycin use: prescribing context is key Joanne Oi Sze ChanMelissa Therese BaysariRichard Osborne Day Pharmacoepidemiology and Prescription 28 July 2018 Pages: 1523 - 1529
